DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the GLOBAL HEALTH LIMITED (MEDANTA) share price today?

GLOBAL HEALTH LIMITED (MEDANTA) is trading at ₹1,316.9 on the NSE, down 1.15% on the day. Source: DocStoX.

What is the PE ratio of GLOBAL HEALTH LIMITED?

GLOBAL HEALTH LIMITED has a price-to-earnings (PE) ratio of 63.6 in the Healthcare sector.

What is the market capitalisation of GLOBAL HEALTH LIMITED?

GLOBAL HEALTH LIMITED has a market capitalisation of approximately ₹35,414 crore.

GLOBAL HEALTH LIMITED

MEDANTA·NSE·Healthcare

₹1,316.90▼ -15.30 (-1.15%)

Healthcare · Hospitals

A steady, established business

NIFTY 500NIFTY MIDCAP 150

Day₹1312.60

₹1337.90

52W₹956

₹145772%

Open

₹1337.00

High

₹1337.90

Low

₹1312.60

Prev Close

₹1332.20

Volume

58.6K

VWAP

₹1321.11

Snapshot

Key fundamentals

Market Cap

₹35,414 Cr

P/E Ratio

63.62Expensive

P/B Ratio

9.15

EPS

₹20.70

Book Value

₹147.00

ROE

15.20%Strong

ROCE

17.00%Decent

Dividend Yield

0.04%

Debt / Equity

0.30Low

Face Value

₹2.00

52W High

₹1456.50

52W Low

₹956.00

Sector

Healthcare

Industry

Hospitals

Avoid

None moatHigh uncertainty

Fair value estimate

₹176

▼ 86.6%downside

Trading at ₹1,317 — 87% above our estimate

BearFair valueBull

₹150₹176₹262

/100

Business quality — Watch the fundamentals

Growth 74Profitability 55Efficiency 23Valuation 43

Plain English

Our view

A steady, established business
Low debt relative to equity
Expensive — trades at 64× earnings

Strengths

Low debt relative to equity
Revenue compounding 18% over 3 years
Profit growing 19% a year

Risks

Expensive — trades at 64× earnings
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

15% ROE fading to 13% over ~3 yrs, on ₹147 book

₹152

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹262

Analyst target

No analyst coverage

—

Blended fair value₹176

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 18% over 3 years
Profit growing 19% a year

Bear case

Expensive — trades at 64× earnings
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

63.6Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

15.2%Strong

Above 15% is considered healthy for Indian equities

ROCE

17.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.30Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹35,414 Cr

P/B

9.15

EPS

₹20.70

Div Yield

0.04%

What changed

Recent changes

Foreign investors-0.4% stake last quarter
Domestic institutions+0.8% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 63.6×

Growth

Strong

+18% rev CAGR

Profitability

Healthy

15.2% ROE

Financial health

Rock solid

D/E 0.30

Momentum

N/A

No technicals

Today

Trading activity

Delivery %49.9%

Turnover₹773.76L Cr

Trades9,795

VWAP₹1321.11

Face value₹2.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+17.6%

+25.0%

10Y

+12.3%

Profit

+19.3%

+80.4%

10Y

+12.5%

EPS

+19.4%

+28.9%

10Y

-5.1%

Profile

Pros

Company has delivered good profit growth of 80.7% CAGR over last 5 years

Watch-outs

Cons

Stock is trading at 9.07 times its book value

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.39 pts; domestic institutions added 0.77 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

33%

Promoter

Promoters

33.0%0.00

Public

42.0%-0.40

FII / FPI

10.2%-0.39

DII

14.8%+0.77

Total shareholders

1,47,390-3,851 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter33.01%

FII10.15%

DII14.76%

Public42.01%

Others0.07%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions